Key Quantitative Figures
- Revenue from Operations: ₹11,488.38 lakhs (FY26) vs ₹11,892.08 lakhs (FY25)
- Total Income: ₹11,650.55 lakhs (FY26) vs ₹12,024.11 lakhs (FY25)
- Profit Before Tax: ₹846.01 lakhs (FY26) vs ₹1,363.42 lakhs (FY25)
- Profit After Tax: ₹743.37 lakhs (FY26) vs ₹961.24 lakhs (FY25)
- EPS (Basic & Diluted): ₹1.64 (FY26) vs ₹2.04 (FY25)
- Total Comprehensive Income: ₹775.44 lakhs (FY26) vs ₹963.51 lakhs (FY25)
- R&D Expenditure: Revenue - ₹262.66 lakhs, Capital - ₹235.65 lakhs (FY25)
- Share Capital: Equity - ₹473.13 lakhs (47,312,741 shares of ₹1 each)
- Borrowing Limit Sought: ₹100 crore under Section 180(1)(c)
- Cost Auditor Remuneration: ₹40,000 plus out-of-pocket expenses
Dates of Action
- AGM Date: September 28, 2026 at 3:00 PM IST through VC/OAVM
- Record Date: September 21, 2026 for e-voting eligibility
- Remote e-voting Period: September 25, 2026 (9:00 AM) to September 27, 2026 (5:00 PM)
- Board Meeting Dates: 13 meetings held during FY26 between April 23, 2025 and March 27, 2026
- Director Appointments:
- Mr. Amulya Kumar Nayak: April 18, 2026
- Mr. Avinash Prabhat: April 4, 2026
- Ms. Reema Goyal: April 4, 2026
Parties Involved
- Statutory Auditors: M/s Neeraj Arora & Associates, Chartered Accountants (FRN: 021309N)
- Secretarial Auditors: M/s Maya Sharma & Associates
- Cost Auditors: M/s Mahesh Singh & Co., Cost Accountants (FRN: 100441)
- RTA: Beetal Financial & Computer Services (P) Limited
- Banker: Kotak Mahindra Bank
- Scrutinizer: M/s Maya Sharma & Associates for e-voting
Business Items for AGM
Ordinary Business
1. Adoption of audited financial statements for FY ended March 31, 2026
2. Re-appointment of Mr. Sameer Goel (DIN: 00161786) as director retiring by rotation
Special Business
3. Approval of remuneration of ₹40,000 for Cost Auditors M/s Mahesh Singh & Co. for FY27
4. Appointment of Mr. Amulya Kumar Nayak (DIN: 11667557) as Director liable to retire by rotation
5. Appointment of Ms. Reema Goyal (DIN: 11266730) as Independent Woman Director for 5 years (April 4, 2026 to April 3, 2031)
6. Appointment of Mr. Avinash Prabhat (DIN: 10997441) as Independent Director for 5 years (April 4, 2026 to April 3, 2031)
7. Approval for increasing borrowing limit to ₹100 crore under Section 180(1)(c)
8. Authorization to create mortgage/charge on company properties for borrowings up to ₹100 crore
9. Approval for loans/guarantees to subsidiaries/associates up to ₹100 crore under Section 185
10. Approval for investments/loans/guarantees up to ₹100 crore under Section 186
Financial Impact
- No dividend declared for FY26
- Profit of ₹743.37 lakhs transferred to reserves
- Preference share capital of ₹800 lakhs redeemed during FY26
- Borrowings outstanding: Non-current ₹2,280.89 lakhs, Current ₹1,181.90 lakhs
- Contingent liabilities: ₹135.58 lakhs (tax demands and penalties)
Capital Structure Impact
- No change in equity share capital during FY26
- Redemption of 80,00,000 preference shares of ₹10 each during FY26
- Proposed borrowing limits may increase debt capacity by ₹100 crore
Operational Highlights
- R&D center approved by DSIR (Registration No. TU/IV-RD/4410/2021)
- Patent granted in January 2026 for Luliconazole (antifungal drug)
- Manufacturing facility compliant with GMP standards and licensed by State FDA, Haryana
- Employee strength: 205 as of March 31, 2026 (vs 250 previous year)
- Export revenue: ₹2,306.41 lakhs (FY26) vs ₹1,729.26 lakhs (FY25)
Governance Updates
- Board composition: 1 Executive MD, 1 Non-Executive Director, 2 Independent Directors including 1 woman director
- Key Managerial Personnel: Mr. Sameer Goel (CEO), Mr. Mani Jain (CFO), Mr. Abhishek Kumar Pandey (CS & Compliance Officer)
- Board met 13 times during FY26
- CSR provisions not applicable as net profit below threshold
Voting Arrangements
- Remote e-voting through NSDL platform
- VC/OAVM facility for AGM attendance
- Scrutinizer appointed for vote counting
- Results to be announced by September 30, 2026